High density lipoprotein cholesterol and apolipoprotein A-I levels in 32–33-year-old women on steroid contraceptives—differences between two frequently used low-estrogen pills

This publication has 21 references indexed in Scilit:

• ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?
  The Lancet, 1979
• Lipoproteins and the inhibitory effect of human endothelial cells on platelet function.
  Circulation Research, 1978
• High-density lipoprotein cholesterol, monthly variation and association with cardiovascular risk factors in 1000 forty-year-old Dutch citizens
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1978
• Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and Progestins
  New England Journal of Medicine, 1978
• REDUCED HIGH-DENSITY LIPOPROTEIN IN WOMEN AGED 40-41 USING ORAL CONTRACEPTIVES
  The Lancet, 1978
• The Tromsø Heart Study: Serum apolipoprotein Al concentration in relation to future coronary heart disease
  European Journal of Clinical Investigation, 1978
• HÆMOSTATIC, LIPID, AND BLOOD-PRESSURE PROFILES OF WOMEN ON ORAL CONTRACEPTIVES CONTAINING 50 µg OR 30 µg ŒSTROGEN
  The Lancet, 1977
• High density lipoprotein as a protective factor against coronary heart disease
  The American Journal of Medicine, 1977
• Quantitation of apolipoprotein A-I of human plasma high density lipoprotein
  Metabolism, 1976
• High density lipoproteins reduce the uptake of low density lipoproteins by human endothelial cells in culture
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976